Oral solid dosage manufacturing companies, equipment and market
Pharmaceutical Technology
by Elli Karampela
6h ago
Discover key insights into the selection of oral solid dosage manufacturing companies and equipment. Learn about the latest technological advancements in the oral solid dosage industry and market ..read more
Visit website
Shionogi secures licence for Maze’s Pompe disease treatment
Pharmaceutical Technology
by Vishnu Priyan
11h ago
Shionogi has concluded an exclusive global licence agreement for Maze Therapeutics’ MZE001 aimed at treating Pompe disease ..read more
Visit website
Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension
Pharmaceutical Technology
by Vishnu Priyan
11h ago
Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmic suspension 0.05% for inflammation after ocular surgery ..read more
Visit website
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology
by Alexander Love
12h ago
GlobalData examines four of the key trends affecting contract research organizations (CROs) involved with infectious diseases ..read more
Visit website
Attovia secures $105m to advance development of lead programmes
Pharmaceutical Technology
by Vishnu Priyan
12h ago
Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes ..read more
Visit website
Novo Nordisk enters deal to develop obesity therapy
Pharmaceutical Technology
by Vishnu Priyan
12h ago
Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biotechnologies to develop therapeutics for obesity ..read more
Visit website
Marinus parts ways with 20% of its workforce
Pharmaceutical Technology
by Justine Ra
20h ago
Marinus expects to share data from the Phase III RAISE trial of IV ganaxolone for the treatment of status epilepticus later in the summer ..read more
Visit website
Novo Holdings-backed Commit launches with $17.2m in seed funding
Pharmaceutical Technology
by Phalguni Deswal
20h ago
The Danish biotech, Commit Biologics, will focus on developing antibody therapies to treat cancer and autoimmune diseases ..read more
Visit website
Acumen doses first patient in Phase II Alzheimer’s disease trial
Pharmaceutical Technology
by Ross Law
20h ago
Acumen Pharmaceuticals has dosed the first patient in the ALTITUDE-AD Phase II trial for its lead drug sabirnetug (ACU193 ..read more
Visit website
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology
by Robert Barrie
1d ago
Workforce optimisation, R&D prioritisation and technology investments are on Takeda’s agenda ..read more
Visit website

Follow Pharmaceutical Technology on FeedSpot

Continue with Google
Continue with Apple
OR